Research Topics
Genomes and Genes
Species | Estella MatutesSummaryAffiliation: Institute of Cancer Research Country: UK Publications
| Collaborators
|
Detail Information
Publications
Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesisP D Thornton
Section of Haemato-Oncology, Institute of Cancer Research, The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
Leuk Res 29:389-95. 2005..We suggest that the relatively high incidence of transformation in this series may be due to immunosuppression mainly related to fludarabine, although other agents and prior therapies may have also contributed...
Case 33. Diagnostic difficulty in a patient with acute leukemiaAllison C Y Tso
Department of Haematology, Hammersmith Hospital, London, UK
Leuk Lymphoma 48:177-9. 2007..A provisional diagnosis of acute myeloid leukemia, FAB type M2, was made in a 24-year-old woman. Immunophenotyping led to reassessment of the diagnosis...
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaE Matutes
Section of Haemato oncology, Institute of Cancer Research, London, UK
Leukemia 22:487-95. 2008....
Differential diagnosis in chronic lymphocytic leukaemiaEstella Matutes
Haemato oncology Department, The Royal Marsden Hospital and Institute of Cancer Research, 203 Fulham Road, London SW3 6JJ, UK
Best Pract Res Clin Haematol 20:367-84. 2007..Fluorescence in-situ hybridization (FISH) analysis also provides prognostic information, chiefly by detecting 17 (p53 locus) and 11q deletion, and may determine the type of therapy...
Splenic marginal zone lymphoma with and without villous lymphocytesEstella Matutes
Haemato Oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, 203 Fulham Road, London, SW3 6JJ, UK
Curr Treat Options Oncol 8:109-16. 2007....
Adult T-cell leukaemia/lymphomaE Matutes
Haemato Oncology Unit, The Institute of Cancer Research Royal Marsden NHS Trust, London, UK
J Clin Pathol 60:1373-7. 2007..Consolidation with high dose therapy and autologous or allogeneic stem-cell transplantation should be considered in young patients...
Diagnostic issues in chronic lymphocytic leukaemia (CLL)Estella Matutes
Section of Haemato Oncology Department, The Royal Marsden Hospital and Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK
Best Pract Res Clin Haematol 23:3-20. 2010..In atypical CLL, histology and/or molecular genetics may be required to exclude other B-cell disorders...
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classificationEstella Matutes
Department of Haemato Oncology, Royal Marsden Hospital, Institute of Cancer Research, London, UK
Blood 117:3163-71. 2011..Age, Ph(+), and AML therapy were predictors for poor outcome (P < .001; P = .002; P = .003). MPAL is confirmed to be a poor-risk disease. Adults and Ph(+) patients should be considered for transplantation in first remission...
Immunophenotyping and differential diagnosis of hairy cell leukemiaEstella Matutes
Department of Haemato Oncology, The Royal Marsden Hospital and Institute of Cancer Research, 203 Fulham Road, London, SW3 6JJ, UK
Hematol Oncol Clin North Am 20:1051-63. 2006..Immunophenotyping is an essential tool for the diagnosis of these two disorders, for monitoring and assessing response to therapy, and for distinguishing them from other B-cell malignancies...
The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patientsE Matutes
Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital NHS Trust, Fulham Road, London SW3 6JJ, UK
Leuk Lymphoma 45:2007-15. 2004..Splenectomy is a useful treatment option in this group of patients...
B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemiaRosa Ruchlemer
Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital and Institute of Cancer Research, London, UK
Br J Haematol 125:330-6. 2004..These cases illustrate the importance of tissue diagnosis with cyclin D1 staining and fluorescence in situ hybridization analysis in B-cell leukaemia with prolymphocytic features...
The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytesIlaria del Giudice
Academic Department of Hematology and Cytogenetics, The Royal Marsden Hospital and Institute of Cancer Research, London, UK
Haematologica 89:303-8. 2004..However CD123 does not allow the distinction between HCL-variant and SLVL, as both are CD123 negative...
Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findingsCaroline L Alvares
Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital, London SW3 6JJ, UK
Leuk Lymphoma 45:769-75. 2004..These cases serve to highlight the biological and cytogenetic heterogenity of DLBL and emphasize the need for complementary investigations in the characterization of this entity...
T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literatureNnenna Osuji
Section of Haemato oncology, Institute of Cancer Research, London, United Kingdom
Cancer 107:570-8. 2006..To the authors' knowledge, there is no standard treatment for patients with T-cell large granular lymphocyte (LGL) leukemia. Available data are limited by patient numbers and coexisting pathologies...
Characterisation of TP53 abnormalities in chronic lymphocytic leukaemiaPatrick D Thornton
Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust and Institute of Cancer Research, London, UK
Hematol J 5:47-54. 2004..DNA sequencing adds little to these methods in identifying the population at risk...
ATM mutations are rare in familial chronic lymphocytic leukemiaMartin R Yuille
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom
Blood 100:603-9. 2002..Common ATM missense mutations were not overrepresented. The data support previous observations that ATM mutation is associated with B-CLL. However, ATM mutations do not account for familial clustering of the disease...
Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locusDalemari Crowther-Swanepoel
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK
Hum Mol Genet 19:1840-5. 2010..These four SNPs map to a 3 kb region of the 3'-UTR of IRF4, consistent with the causal basis of the association being mediated through differential IRF4 expression...
Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patientsNilima Parry-Jones
Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust, London, UK
Br J Haematol 120:759-64. 2003..001 for SLVL deaths). We conclude that SLVL is mainly a disease of the elderly with a relatively benign course but, when treatment is required, splenectomy is beneficial...
Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatmentNnenna Osuji
Section of Haemato-Oncology, Department of Histopathology, Institute of Cancer Research, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, United Kingdom
Leuk Res 29:225-8. 2005..We highlight the resistant nature of the LGL clone and discuss the relative merits of immunomodulatory type therapy in this disease...
CD38 expression as a prognostic indicator in chronic lymphocytic leukaemiaPatrick D Thornton
1Academic Department of Haematology and Cytogenetics, Institute of Cancer Research and Royal Marsden NHS Trust, London, UK
Hematol J 5:145-51. 2004..We conclude that 7% may be a more useful threshold for disease progression than higher values of CD38...
Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytesAlicja M Gruszka-Westwood
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research/Royal Marsden NHS Trust, London, United Kingdom
Genes Chromosomes Cancer 36:57-69. 2003..The presence of a high incidence of abnormalities in the established hotspot areas and in particular the finding of biallelic deletions is indicative of the existence of genes important for the pathogenesis of SLVL in these areas...
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel
Institute of Cancer Research, Sutton, Surrey, UK
Nat Genet 42:132-6. 2010..2 (rs783540, CPEB1; OR = 1.18; P = 3.67 x 10(-6)) and 18q21.1 (rs1036935; OR = 1.22; P = 2.28 x 10(-6)). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy...
Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemiaVasantha Brito-Babapulle
FRC Path, Academic Department of Hematology and Cytogenetics, Royal Marsden NHS Trust Institute of Cancer Research, 203, Fulham Road, London SW3 6JJ, UK
Haematologica 87:357-62. 2002....
Diagnostic significance of CD20 and FMC7 expression in B-cell disordersJulio Delgado
Academic Department of Haematology and Cytogenetics, Royal Marsden NHS Trust, Institute of Cancer Research, London, England
Am J Clin Pathol 120:754-9. 2003..FMC7 is of greater diagnostic value than CD20 for distinguishing CLL from other B-cell disorders; we recommend its continued use for this purpose...
Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometryP Jain
Department of Academic Haematology and Cytogenetics, The Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK
J Clin Pathol 55:940-5. 2002..Further comparisons between flow cytometry, IHC, and FISH may be needed to ascertain the diagnostic value of the flow cytometric assay...
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)M Mansour Ceesay
Department of Haematological Medicine, King s College Hospital NHS Foundation Trust and King s College London, London, UK
Leuk Res 36:857-61. 2012..In conclusion CHOP-Z is safe and in those who achieve a complete response it was associated with prolonged overall survival...
Causation of chronic lymphocytic leukemia--insights from familial diseaseRichard S Houlston
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK
Leuk Res 27:871-6. 2003..Here, we review the current status of knowledge about inherited susceptibility to CLL...
Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemiaRosa Ruchlemer
Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust, London, UK
Br J Haematol 118:952-8. 2002..Differences seen between MCL and CLL in spleen size, and in response of the leucocytosis suggest a central role for the spleen in the evolution of MCL with leukaemia...
Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2AManal O Elnenaei
Academic Department of Haematology and Cytogenetics, The Institute of Cancer Research and Royal Marsden Hospital Trust, 203 Fulham Road, London SW3 6JJ, UK
Haematologica 88:529-37. 2003..The incidence of the latter two events was, however, higher than previously reported. Deletion of the TP53 gene predicted resistance to chemotherapy, highlighting its importance in this disease process...
Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisationHannah C Rudenko
Section of Haemato oncology, The Institute of Cancer Research ICR, Sutton, Surrey, London, UK
Leuk Lymphoma 49:1879-86. 2008..02). In particular, amplification of 2p and deletion of 6q were both more frequent. Cases with >20%TP53-deleted cells had the worst prognosis in the LRF CLL4 trial...
p53 abnormalities in splenic lymphoma with villous lymphocytesA M Gruszka-Westwood
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research/Royal Marsden NHS Trust, Fulham Rd, London, SW3 6JJ United Kingdom
Blood 97:3552-8. 2001..Although p53 abnormalities are infrequent in SLVL, they underlie a more aggressive disease course and poor prognosis. (Blood. 2001;97:3552-3558)..
CD52 expression in T-cell large granular lymphocyte leukemia--implications for treatment with alemtuzumabN Osuji
Section of Haemato-Oncology, Royal Marsden NHS Trust and Institute of Cancer Research, London, UK
Leuk Lymphoma 46:723-7. 2005..The strong and consistent expression of CD52 shown here highlights the potential role of alemtuzumab in the treatment of refractory T-cell LGL leukemia and possibly aggressive NK cell leukemia...
Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patientsSaeed Al-Shieban
Department of Histopathology, Hammersmith Hospital Campus, Imperial College Healthcare NHS Trust, London, and Imperial College London, UK
Br J Haematol 154:466-70. 2011..This study provides a practical strategy to distinguish haematogones from B-ALL cells in BMTB...
Granulomatous slack skin disease--disease features and response to pentostatinNnenna Osuji
Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London, UK
Br J Haematol 123:297-304. 2003..The patient has twice achieved a good response to pentostatin after failure of combination chemotherapy. This is the first report of the successful use of the purine analogue pentostatin in the management of GSSD...
Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative reviewNnenna Osuji
Section of Haemato oncology, Royal Marsden Hospital Foundation Trust Institute of Cancer Research, London UK
Am J Surg Pathol 29:935-41. 2005....
CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual diseaseMariano P Scolnik
Inmunología Oncológica, IIHEMA, Academia Nacional de Medicina de, Buenos Aires, Argentina
Leuk Res 26:615-9. 2002..Our results indicate that quantitative analysis of CD34 and CD117 may be useful to detect minimal residual disease (MRD) and could be tested in a future to monitor therapy in AML...
Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trialDavid Gonzalez
Section of Haemato oncology, The Institute of Cancer Research, London, United Kingdom
J Clin Oncol 29:2223-9. 2011..We aimed to address the frequency and prognostic value of TP53 abnormalities in patients with CLL in the context of a prospective randomized trial...
p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndromeV Brito-Babapulle
Department of Academic Haematology Cytogenetics, Royal Marsden Hospital NHS Trust and Institute of Cancer Research, London, UK
Br J Haematol 110:180-7. 2000..Alternatively, the frequent loss of the p53 gene could be associated with the deletion of an adjacent gene, which could be involved in the pathogenesis of these diseases...
Definition of acute biphenotypic leukemiaE Matutes
Academic Department of Hematology and Cytogenetics, Royal Marsden Hospital, London, UK
Haematologica 82:64-6. 1997..In this work we analyze diagnostic criteria for BAL...
Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomaL Hendry
Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK
Leuk Lymphoma 45:945-50. 2004..The role of FCM as first line therapy deserves study as well as its combination with the monoclonal antibody Rituximab...
Morphological and immunophenotypic features of chronic lymphocytic leukemiaE Matutes
Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital and Institute of Cancer Research, Fulham Road, London, SW3 6JJ, UK
Rev Clin Exp Hematol 4:22-47. 2000..Both provide relevant information in terms of diagnosis, course of the disease, prognosis and pathogenesis...
Deletions of D13S25, D13S319 and RB-1 mapping to 13q14.3 in T-cell prolymphocytic leukaemiaV Brito-Babapulle
Academic Department of Haematology and Cytogenetics Institute of Cancer Research, London, UK
Br J Haematol 114:327-32. 2001..Thus, 13q14.3 deletions could contribute to the development of overt leukaemia in T-PLL, but the involvement of more than one gene in the region cannot be excluded...
Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphomaE Matutes
Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, NHS Trust, Fulham Road, London SW3 6JJ, UK
Br J Haematol 115:801-6. 2001..This is the first case documented by molecular methods of the transformation of the pre-existing clone...
The variant form of hairy-cell leukaemiaE Matutes
Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
Best Pract Res Clin Haematol 16:41-56. 2003..Transformation to large cell is seen in 6% of patients. The inferior survival in HCL-variant compared with typical HCL cases may reflect the chemotherapy resistance...
New additions to antibody panels in the characterisation of chronic lymphoproliferative disordersE Matutes
Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital and Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK
J Clin Pathol 55:180-3. 2002..Those monoclonal antibodies that are relevant to the characterisation of the chronic lymphoproliferative disorders and that could be incorporated in a routine practice are discussed...
Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemiaN Osuji
Section of Haemato oncology, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Sutton, Surrey, UK
Histopathology 50:547-54. 2007..To augment the limited literature on bone marrow (BM) appearances in T-cell large granular lymphocyte (LGL) leukaemia and to identify a histological signature to aid in diagnosis of this condition...
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialD Catovsky
Section of Haemato oncology, Institute of Cancer Research, Sutton, UK
Lancet 370:230-9. 2007..We aimed to establish whether this treatment combination provided greater survival benefit than did chlorambucil or fludarabine...
Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemiaE Tuset
Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust, London, UK
Leuk Lymphoma 42:1379-83. 2001..The reasons for the immunophenotypic changes are unknown but it is likely that loss of CD52 antigen expression contributed to the resistance to CAMPATH-1H in one of the patients when re-treated...
Teaching cases from the Royal Marsden and St Mary's Hospital case 29: striking generalized lymphadenopathy in 'acute myeloid leukemia'Philip Beer
Department of Hematology, St Mary's Hospital, London, UK
Leuk Lymphoma 46:155-6. 2005
Teaching cases from the royal marsden and St Mary's Hospitals. Case 22: an unusual cause of lymphocytosisKetan C Patel
Department of Haematology, St Mary's Hospital, London, UK
Leuk Lymphoma 43:923-5. 2002
Alemtuzumab in T-cell malignanciesClaire E Dearden
St George s Hospital Medical School, London, UK
Med Oncol 19:S27-32. 2002..We conclude that treatment with alemtuzumab may offer new hope to patients who otherwise have a bleak prognosis...
Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion geneAlicja M Gruszka-Westwood
Academic Department of Haematology and Cytogenetics, Royal Marsden NHS Trust, London, UK
Genes Chromosomes Cancer 33:206-12. 2002..This is to our knowledge the first description of amplification of the CCND1/IGH fusion gene in a human neoplasm, which may have played a role in the fulminating course of the disease in this patient...
High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalitiesPatrick D Thornton
Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust, London, UK
Ann Hematol 82:759-65. 2003..This study demonstrates that HDMP alone or in combination with other agents is a useful treatment strategy in refractory CLL including patients with p53 abnormalities...
Prolonged treatment response in aggressive natural killer cell leukemiaN Osuji
Section of Haemato-Oncology, Royal Marsden NHS Trust/Institute of Cancer Research, London, UK
Leuk Lymphoma 46:757-63. 2005....
Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paperM Dungarwalla
Haemato Oncology Unit, The Royal Marsden Hospital, London, UK
Eur J Haematol 80:469-76. 2008..While allogeneic stem cell transplant is an attractive option, due to the older age group of T-PLL patients the morbidity and mortality associated with the procedure is significant...
Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemiaI A Astsaturov
Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital, London, UK
Leukemia 10:769-73. 1996..B29 (CD79b) is present in the membrane at a later stage compared to its cytoplasmic expression and found in mature B blasts (B-ALL) that express membrane Ig as it is in normal and leukaemic B lymphocytes...
Prolymphocytic leukemiasBiju Krishnan
Department of Haemato-Oncology, The Royal Marsden Hospital and Institute of Cancer Research, London, UK
Semin Oncol 33:257-63. 2006..In particular, the use of Campath-1H, in T-PLL has more than doubled median survival. The role of allogeneic transplant with nonmyeloablative conditioning needs to be explored further...
Chronic T-cell lymphoproliferative disordersEstella Matutes
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research, The Royal Marsden Hospital, London, UK
Rev Clin Exp Hematol 6:401-20; discussion 449-50. 2002
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemiaMaria Chiara Di Bernardo
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK
Nat Genet 40:1204-10. 2008..32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). These data provide the first evidence for the existence of common, low-penetrance susceptibility to a hematological malignancy and new insights into disease causation in CLL...
Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemiaMartin Yuille
Academic Department of Haematology and Cytogenetics, and the Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom
Blood 99:4216-8. 2002..8-fold (OR = 2.8, 95% confidence interval: 1.1-6.9). Our findings suggest that heritable GST status may influence the risk of developing CLL...
Deoxycoformycin in the treatment of mature T-cell leukaemiasC Dearden
Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London, UK
Br J Cancer 64:903-6. 1991..We conclude that DCF is a useful therapy for the treatment of T-cell leukaemias, in particular Sezary syndrome and T-PLL, and should play a part in strategies to improve the natural history of this group of lymphoid malignancies...
A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disordersS P Sah
Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital, 203 Fulham Road, London SW3 6JJ, UK
J Clin Pathol 56:129-32. 2003..FC might be slightly more sensitive than BMB to detect MRD in CLL, whereas BMB may be slightly better than FC in NHL...
High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosisM Dungarwalla
Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK
Br J Haematol 143:71-4. 2008..03). While transformation in the bone marrow is frequently refractory to therapy and associated with poor outcome in SMZL, lymph node transformation responds well to chemotherapy with durable progression-free and overall survival...
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignanciesM O Elnenaei
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research and Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK
Leuk Res 25:115-23. 2001..We concluded that the detection of cyclin D1 expression by flow cytometry in cell suspensions could be applied routinely to the study of B-lymphoproliferative disorders and may be of value for their diagnosis and management...
Teaching cases from the Royal Marsden and St Mary's Hospitals case 25. A young boy with massive bilateral renal enlargementClaire Hemmaway
Department of Haematology, St Mary's Hospital, Praed Street, London, W2 1NY, UK
Leuk Lymphoma 45:1301-3. 2004
Breakpoints in the ataxia telangiectasia gene arise at the RGYW somatic hypermutation motifPaul S Bradshaw
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research, Sutton, Surrey, UK
Oncogene 21:483-7. 2002..The structures of the ATM duplications suggest they may arise from an error in somatic hypermutation. We suggest that aberrant components of somatic hypermutation may contribute to the defective DSB repair characteristic of cancer...
First report of fludarabine in gamma-heavy chain diseaseS Agrawal
Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London
Br J Haematol 88:653-5. 1994..This response has, so far, been sustained for 2 1/2 years after stopping treatment...
Acute erythroid leukemia (M6): outcome of bone marrow transplantationS Killick
Leukaemia Unit, The Royal Marsden NHS Trust and Institute of Cancer Research, London, UK
Leuk Lymphoma 35:99-107. 1999..The disease is sensitive to AML induction regimens and long-term survival can be achieved with BMT in first complete remission...
Isolated central nervous system involvement in adult T-cell lymphoma/leukaemiaM Dungerwalla
Section of Haemato-Oncology, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK
Br J Haematol 130:511-5. 2005..We also describe objective response to antiviral therapy. To our knowledge, this is the first report of such presentation and response...
ATM is usually rearranged in T-cell prolymphocytic leukaemiaM A Yuille
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research Royal Marsden Hospital NHS Trust, London, UK
Oncogene 16:789-96. 1998..The mechanism of inactivation appeared to be unusual because multiple structural lesions on one allele were often observed...
Lymphopain, a cytotoxic T and natural killer cell-associated cysteine proteinaseJ Brown
Leukaemia Research Fund Centre at the Institute of Cancer Research, Chester Beatty Laboratories, London, UK
Leukemia 12:1771-81. 1998..The cellular distribution of lymphopain expression, together with the functional demonstration of lymphopain-associated proteinase activity in vitro, is suggestive of a role for lymphopain in immune cell-mediated, cell killing...
Prospective study of HTLV-I infection in an initially asymptomatic cohortG P Taylor
Clinical Trials Centre, Imperial College School of Medicine, St Mary s Hospital, London, UK
J Acquir Immune Defic Syndr 22:92-100. 1999..Persistently high proviral load appears to predate the development of HTLV-I-associated inflammation in neuro-ophthalmic tissue...
Microsatellite instability indicative of defects in the major mismatch repair genes is rare in patients with B-cell chronic lymphocytic leukemia: Evaluation with disease stage and family historyG S Sellick
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK
Leuk Lymphoma 48:1320-2. 2007..In conclusion, our study demonstrates that MSI does not have a prominent role in the pathogenesis of B-CLL...
Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysisB Summersgill
UK Co-ordinating Centre for the Study of Familial Chronic Lymphocytic Leukaemia, Section of Molecular Carcinogenesis, Institute of Cancer Research, Sutton, UK
Leukemia 16:1229-32. 2002..This suggests these regions may harbour a susceptibility locus for CLL. There is also some evidence that chromosome regions 2p12-p14 and 4q11-q21 may harbour predisposition genes...
Response to cyclosporine in a patient with disseminated granuloma annulare associated with CD4+/CD8+(dim)/CD56+ large granular lymphocytic leukemiaElisa Granjo
Arch Dermatol 138:274-6. 2002
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemiaMonica Else
Section of Haemato oncology, Royal Marsden Hospital Institute of Cancer Research, Sutton, United Kingdom
Cancer 110:2240-7. 2007..They continue to be effective at second- and even third-line therapy; however, alternative treatments are needed for patients who are or have become refractory to these agents or whose remissions are shorter with each course of therapy...
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemiaClaire Dearden
Royal Marsden National Health Service NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK
Blood 111:1820-6. 2008..In conclusion, DAT status at the time of initiation of therapy provides a new prognostic indicator, although FC may protect against AHA. This trial was registered at http://isrctn.org as no. 58585610...
The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven casesYang O Huh
Department of Hematopathology, MD Anderson Cancer Centre, The University of Texas, Houston, TX 77030, USA
Br J Haematol 136:220-8. 2007..However, these neoplasms also differ from CLL cytologically and in their immunophenotype...
Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansionAndy C Rawstron
Academic Unit of Haematology and Oncology, University of Leeds, HMDS, West Yorkshire, Surrey, United Kingdom
Blood 100:2289-90. 2002..The detection of CLL-phenotype cells provides a surrogate marker of carrier status, potentially facilitating gene identification through mapping in families and direct analysis of isolated CLL-phenotype cells...
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal diseaseJenny Orchard
Department of Haematology, Royal Bournemouth Hospital, United Kingdom
Blood 101:4975-81. 2003..We find no evidence against a diagnosis of MCL in the nonnodal group and suggest that mutated IgVH genes may help identify patients with indolent disease...
[Chronic lymphoproliferative syndromes in Chile. A prospective study in 132 patients]Maria Elena Cabrera
Departamento de Medicina, Campus Oriente, Facultad de Medicina, Universidad de Chile, Servicio de Medicina, Hospital del Salvador, Santiago
Rev Med Chil 131:291-8. 2003..Chronic lymphoproliferative disorders include a variety of diseases which are often a diagnostic problem for clinical hematologists...
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutationsAnne Tierens
Departments of Pathology and Tumor Biology, The Norwegian Cancer Institute and Radiumhospital, University of Oslo, Oslo, Norway
Am J Pathol 162:681-9. 2003..Our results indicate that marginal zone lymphomas at different anatomical localizations may derive from a similar B-cell subset...
Alemtuzumab in T-cell lymphoproliferative disordersClaire E Dearden
Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK
Best Pract Res Clin Haematol 19:795-810. 2006....
Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 yearsMonica Else
Section of Haemato-Oncology, Royal Marsden NHS Foundation Trust/Institute of Cancer Research (ICR, Sutton, United Kingdom
Cancer 104:2442-8. 2005..True cure in HCL remains elusive, but the addition of monoclonal antibodies may be beneficial. Our results suggest that achieving CR should remain the main goal of treatment...
Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populationsElisa Granjo
Department of Clinical Haematology, Hospital Geral de São João, Porto, Portugal
Br J Haematol 119:629-33. 2002....
Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemiaIlaria del Giudice
Section of Hemato-Oncology, Institute of Cancer Research, Sutton, Surrey, United Kingdom
Cancer 104:2124-32. 2005..00001). CONCLUSIONS: The current findings suggested that both ZAP-70 and CD38 should be tested prospectively in all patients with early-stage CLL...
Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridizationClaus L Andersen
Department of Hematology, Laboratory of Cancer Cytogenetics, Arhus Sygehus, Tage Hansens Gade 2, DK-8000 Arhus C, Denmark
Cancer Genet Cytogenet 156:122-8. 2005..Our data suggest that SMZL constitute a genetically heterogeneous disease where gain of 3q25 and loss of 7q31 are the most likely imbalances to be involved in the pathogenesis of the disease...
The WHO classification of mature T-cell leukemiasDaniel Catovsky
Blood 104:2989-90; author reply 2990. 2004
The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemiaGabrielle S Sellick
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey
Cancer Epidemiol Biomarkers Prev 13:1065-7. 2004..80-1.31). A meta-analysis of this study and five other smaller published studies provides no evidence of relationship between this P2X7 polymorphism and risk of CLL (odds ratio = 0.99, 95% confidence interval: 0.74-1.32)...
MTHFR polymorphisms and risk of chronic lymphocytic leukemiaMatthew F Rudd
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom
Cancer Epidemiol Biomarkers Prev 13:2268-70. 2004..97 (95% CI, 0.79-1.18) and 0.88 (95% CI, 0.62-1.24), respectively. This data indicate that the MTHFR polymorphisms C677T and A1298C do not significantly contribute to an inherited genetic susceptibility to CLL...
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responsesDonald W Milligan
Department of Haematology, Birmingham Heartlands Hospital, Birmingham, United Kingdom
Blood 105:397-404. 2005..Detectable molecular disease by PCR was highly predictive of disease recurrence. It is of concern that 5 of 65 (8%) patients developed posttransplant acute myeloid leukemia/myelodysplastic syndrome...
Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphomaGunhild Trøen
Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Montebello N 0310, Oslo, Norway
J Mol Diagn 6:297-307. 2004....
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLLDalemari Crowther-Swanepoel
Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom
Blood 111:5691-3. 2008..These observations provide evidence that familial CLL is essentially indistinguishable from sporadic CLL, favoring a genetic basis to disease development in general rather than a simple environmental etiology...
Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemiaIlaria del Giudice
Haematologica 90:268-70. 2005..During follow-up post-treatment, seven delayed responses (54%) were observed, improving the initial overall response rate of 61% to a final response rate of 77%...
Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemiaNnenna Osuji
Section of Haemato-Oncology, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, Surrey SM2 5PT, UK
Br J Haematol 128:645-8. 2005..Pregnancy thus appears to have a beneficial effect on neutrophil count in T-cell LGL leukaemia...
Delineation of the minimal region of loss at 13q14 in multiple myelomaManal O Elnenaei
Department of Academic Haematology and Cytogenetics, The Institute of Cancer Research and Royal Marsden NHS Trust, London, United Kingdom
Genes Chromosomes Cancer 36:99-106. 2003..However, a role for RFP2 in the pathogenesis of MM cannot yet be excluded, given that alternative mechanisms such as haploinsufficiency remain possible...
A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility lociGabrielle S Sellick
Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom
Am J Hum Genet 77:420-9. 2005..01). None of the regions coincided with areas of common chromosomal abnormalities frequently observed for CLL. These findings strengthen the argument for an inherited predisposition to CLL and related B-cell LPDs...
The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53Nnenna C Osuji
Haematologica 90:1435-6. 2005..214). We confirm the efficacy of alemtuzumab in refractory CLL irrespective of p53 deletions, and advocate its introduction earlier in disease course...
High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemiaDonald W Milligan
Department of Haematology, Birmingham Heartlands Hospital, Birmingham B9 5SS, UK
Br J Haematol 133:173-5. 2006..4% (95% confidence interval, 2.5-24%). No analysed potential risk factor was predictive for MDS/AML development. We hypothesise that potential causative factors are fludarabine, low cell dose and transplant conditioning...
p53 and mdm2 in mantle cell lymphoma in leukemic phaseMax Solenthaler
Central Hematology Laboratory, University Hospital, Inselspital, Bern, Switzerland
Haematologica 87:1141-50. 2002..This study aimed to assess the frequency, relationship and impact of p53 abnormalities and those of its inhibitor mdm2 in blastoid and non-blastoid MCL in leukemic phase...
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapyMoez Dungarwalla
Haematologica 93:475-6. 2008..Despite its efficacy the combination is not easily manageable because of the high rate of opportunistic infections...
